4th Quarter - Report

PODESTA GROUP, INC. for NOVARTIS SERVICES, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Vaccine Issues Pandemic Influenza H. R. 4703, Vaccine Shortage Preparedness Act of 2008 H. R. 4704, Medicare Improvement Act of 2007 H.R. 4705, Vaccines for the Uninsured Adult Act of 2008 S. 3678 / PL 109-417 All Pandemic and All-Hazards Act Section 317 program issues H.R. 4993, Vaccines for the Uninsured Adult Act of 2008 H.R. 4992, Medicare Improvement Act of 2007 H.R. 4991, Vaccine Shortage Preparedness Act of 2008 H.R. 4990, Vaccines for Children Access Act of 2008 S.2466, Vaccines for the Uninsured Adult Act of 2008 S.2465, Vaccines for Children Access Act of 2008 S.2464, Medicare Improvement Act of 2007 S.2467, Vaccine Shortage Preparedness Act of 2008

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

LobbyistCovered position, as disclosed
PAUL BRATHWAITE New Exec. Dir., Congressional Black Caucus
SHARON COHEN —
DAVID MORRISON House Approps. Defense Subcmttee, Staff Dir.
ANTHONY PODESTA —
JOHN SCOFIELD Ass't Press Sec'y, Sen. Mark Hatfield
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
DONNI TURNER New Legislative Assistant, Senator Richard Durbin
NICOLE C YOUNG New —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 4990 (110th), H.R. 4705 (110th), S. 2465 (110th), H.R. 4704 (110th), S. 2466 (110th), H.R. 4992 (110th), S. 2467 (110th), H.R. 4991 (110th), S. 2464 (110th), S. 3678 (110th), H.R. 4703 (110th), H.R. 4993 (110th)

Budget/Appropriations BUD

H.R. 2642, Supplemental Appropriations Act, 2008, pandemic influenza funding LHHS Appropriations, pandemic influenza funding S. 3604, Emergency Supplemental Appropriations for Economic Recovery for Fiscal Year 2008 H.R. 7110, Job Creation and Unemployment Relief Act of 2008

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

LobbyistCovered position, as disclosed
PAUL BRATHWAITE New Exec. Dir., Congressional Black Caucus
SHARON COHEN —
DAVID MORRISON House Approps. Defense Subcmttee, Staff Dir.
ANTHONY PODESTA —
JOHN SCOFIELD Ass't Press Sec'y, Sen. Mark Hatfield
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee
DONNI TURNER New Legislative Assistant, Senator Richard Durbin
NICOLE C YOUNG New —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3604 (110th), H.R. 7110 (110th), H.R. 2642 (110th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
NOVARTIS VACCINES AND DIAGNOSTICS, INC. Switzerland Switzerland 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.